Advancing Cell & Gene Therapy Development & Manufacturing

Our mission is to continuously improve patient access to breakthrough regenerative medicine by improving the speed, cost and quality of developing and manufacturing clinical grade material.
Image

35,000 ft²

Operational Space
Image

GMP Mfg.

Grade B / ISO-7 Suites

Image

FDA Registered

Quality Systems & Facilities
Image

2019

Year Established

Image

70+

Experts on Staff

BioCentriq

BioCentriq is a boutique, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing.

With over 70 scientists, engineers, analysts, and manufacturing specialists, we have established quality systems and expertise to support the release of both autologous and allogeneic drug products.

BioCentriq also specializes in viral vector process development and manufacturing and has expertise in a variety of cell and vector types. 

Our 35,000 square feet of facilities include five ISO-7 certified GMP manufacturing suites, a fully equipped process development laboratory, quality control and analytical method development laboratories, and training facilities.

Image

Get to know BioCentriq and experience the innovative, open, collaborative, highly attentive and pragmatic approach we bring to every project.

Image

What we do

Our goal is to advance the manufacturing of cell and gene therapies to make them more accessible to patients.

We work with small and medium-sized biotech companies who are preparing for an IND submission or manufacturing supplies for their Phase 1 industry-sponsored clinical trial.

Other clients, who conducted IND-enabling studies or manufactured Phase 1 material elsewhere, transfer their technology to BioCentriq to manufacture supplies for their upcoming Phase 2 or Phase 3 trial. 
Image

How we do it

BioCentriq's process development and MS&T (Manufacturing Science & Technology) teams specialize in helping small and mid-size biotech optimize and scale their cell and gene therapies for clinical manufacturing.

Our tech transfer process is designed to be highly collaborative for client teams who want to join us on site at every stage.

Even after we reach engineering runs and clinical manufacturing, we continue to allow room for deep collaboration and on-site support from our clients.

Image

Who we work with

In addition to offering support to small and medium-sized biotechs, we offer workforce development, process development and manufacturing support for big pharma.

We also lead technology application projects that explore and validate the potential impact when novel and emerging technologies are applied during the manufacturing process.

Lastly, on behalf of McKinsey & Partners, we operate the only Digital Capability Center focused on life sciences.

Image

What we do

Our goal is to advance the manufacturing of cell and gene therapies to make them more accessible to patients. Our clients are small and medium-sized biotech companies who are preparing for an IND submission or their Phase 1 industry-sponsored clinical trial.

We also have clients who manufactured their Phase 1 or Phase 2 material elsewhere and because of our expertise, transferred their technology to BioCentriq to manufacture supplies for their upcoming Phase 2 or Phase 3 trial.

Read More
Image

How we do it

Our process development and MSAT (Manufacturing Science and Technology) teams specialize in helping small and mid-size biotech optimize and scale their cell and gene therapies for clinical manufacturing.

Our tech transfer process is also designed to be highly collaborative for client teams who want to join us on site at every stage. Our facilities, infrastructure, people, quality systems and regulatory services are prepared to support commercial manufacturing.
Read More
Image

Who we work with

We also work with big pharma and technology developers on workforce development programs that support the cell and gene industry as well as technology application projects that explore the potential impact when novel and emerging technologies are applied during the manufacturing process. Lastly, on behalf of McKinsey & Partners, we operate the only Digital Capability Center focused on life sciences.
Read More

    Why BioCentriq

    Image

    Hybrid Team Models

    Image
    Exceptional Expertise in MS&T
    Image
    Newly Constructed Facilities
    Image
    World Class Quality Systems
    Image
    Client Maintains Ownership of IP Including Process Improvements
    Image

    Access to Innovation Created Through Technology Partnerships

    Image
    Experienced and Expert Regulatory Advisory Services for CGT
    Image
    High Levels of Customer Satisfaction and Flexible Contracting
    Contact Us

    Latest updates

    Jackie Veivia-Panter Joins BioCentriq as Chief Quality and Compliance Officer

    December 8, 2022

    Setting the Stage for Successful Clinical Manufacturing of Cell and Gene Therapies Webinar 

    November 30, 2022

    BioCentriq Celebrates New Facility in South Brunswick, NJ with Ribbon Cutting and Town Hall 

    October 28, 2022

    Setting the Stage for Successful Clinical Manufacturing of Cell and Gene Therapies Webinar 

    November 30, 2022

    BioCentriq Celebrates New Facility in South Brunswick, NJ with Ribbon Cutting and Town Hall 

    October 28, 2022

    BioCentriq’s CEO to Present at ARM’s Cell & Gene Meeting on the Mesa, October 11-13, 2022 

    October 4, 2022

    BioCentriq in the news

    SEE MORE

    Upcoming events

    SEE ALL EVENTS

    Join our team

    We are looking for passionate and driven individuals with a background in cell and gene therapy to join our growing team. If you thrive in a fast-paced, always evolving environment and embrace the mission of making cell and gene therapies accessible to the patients who need them, we want to hear from you! Please browse our current job listings or contact our HR team.
    SEE ALL LISTINGS

    Get In Touch

    • This field is for validation purposes and should be left unchanged.